Skip to main content
. 2019 Aug 19;75(4):696–701. doi: 10.1093/gerona/glz161

Table 1.

Participants’ Characteristics (n = 87)

Characteristics N (%) or Median (IQR)
Age, years 66 (IQR: 52–78.5)
Sex, female 50 (57.47%)
White matter hyperintensities (0–9 points) 1.50 (IQR: 0.50–5.00)
Hand grip strengthb, kg 25.50 (IQR: 21–36)
Ankle vibration sensitivityb, seconds 10 (IQR: 7–13)
Number of comorbiditiesc
 0 45 (52.33%)
 1 27 (31.40%)
 2 10 (11.63%)
 3 3 (3.49%)
 4 1 (1.16%)
 5 0 (0.00%)
DAT 2.92 (IQR: 2.48–3.42)
UPDRSm 2 (IQR: 1.0–6.0)
UPDRS Axial 21 (25.30%)
UPDRS Bradykinesia 49 (56.32%)
UPDRS Tremor 37 (44.60%)
UPDRS Rigidity 21 (25.30%)
Two or more Parkinsonian signs 46 (52.87%)
Race, white 75 (86.21%)
Education (years) 14 (IQR: 13–16)
Body mass index (kg/m2) 27.02 (IQR: 23.42–30.16)
MMSE score, points 30 (IQR: 29–30)
Depressiona 13 (14.94%)

Note: DAT = Dopamine transporter binding levels; IQR = Interquartile range; MMSE = Mini-Mental State Examination; UPDRS-m = Unified Parkinsonian Disease Rating Scale, motor.

aBy self-report; bright side. cBy self-report, comorbidities include: TIA, stroke, diabetes, hypertension, heart problems.